OIS co-chairs and VCs Emmett Cunningham, MD, Gil Kliman, MD, and Bill Link, PhD, sit down with OISTV to review the highlights of the May 5 OIS@ASCRS in New Orleans. Topics include the purpose for OIS, plans for future meetings, and advances in ophthalmology treatments.
00:52 – The benefit of the breakout sessions.
01:59 – One of the challenges we face at OIS.
2:31 – Why does everyone want to be together?
3:11 – Here everyone is committed to that innovation.
3:40 – WTF is WTF@OIS?
5:05 – Watching the rise of MIGS.
7:30 – Reviewing the Masters of the Universe Panel.
9:25 – No one is on their cell phone; everyone is engaged.
10:09 – Bill Link: It’s amazing to play a role in innovation that helps people.
11:00 – Previewing OIS@ASRS
Tom serves as Content Director for Healthegy, joining the company in 2014, to create and manage a new line of podcasts, publications and other editorial products.
Emmett T. Cunningham Jr., MD, PhD, MPH
Dr. Cunningham joined Clarus Ventures with 20+ years in the biomedical and biopharmaceutical sectors. Prior, Dr. Cunningham was the SVP, Medical Strategy at Eyetech Pharmaceuticals.
William J. Link, PhD
Bill was Founder, Chairman and CEO of Chiron Vision, sold in 1997. Bill founded and served as President of American Medical Optics (AMO), sold in 1986.
Gilbert H. Kliman, MD
Dr. Gil Kliman leads the medical device investment team at InterWest Partners and invests in a broad array of healthcare opportunities, with a special interest in ophthalmology and digital health.